Trial Profile
Clinical Trials Insight: 700039573
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Dec 2008
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 11 Apr 2007 New trial record.